Eosinopenia As A Diagnostic Marker OF Sepsis IN Critically ill Patients

Abstract

Sepsis refers to the presence of a serious infection that correlates with systemic and uncontrolled immune activation. A few studies have analyzed eosinophil count as a prognostic marker of outcome in patients with infection. Eosinopenia is an interesting biomarker because the eosinophil count is always measured in clinical practice and the additional costs would therefore be negligible. The aim of this Study was to test the value of Eosinopenia in the diagnosis of sepsis in critically ill patients admitted to ICUs. This study was a prospective observational, randomized single‑center study it was conducted on 50 adult critically ill patients who were admitted to ICU of Ahmed Maher Teaching Hospital either had sepsis on admission or not. They were in the period from March. 2017- July. 2017. An informed written consent was obtained from patients and/or relatives before starting this this study. Inclusion Criteria were patients more than 18 years old and less than 60 years that were critically ill either in sepsis or not. Exclusion Criteria were Patients less than 18 years old and more than 60 years old, patient or relatives who refused to be included in this study, those with hematological cancer, HIV infection, bronchial asthma